NCT05992194

Brief Summary

Traumatic brain injury (TBI) is a condition that occurs when a mechanical blow to the head causes damage to the brain. The diagnosis of this pathology requires the evaluation of several dimensions, including clinical symptoms, physical signs, cognitive disorders, behavioral and sleep disturbances and state of consciousness. This multidimensional approach provides a comprehensive and accurate assessment of head injury and its severity. The Berlin Consensus of the International Conference on Concussion in Contact Risk Sports held in Berlin in 2016 (McCrory et al., 2017) emphasized that the management of a CTE must be multimodal and multidisciplinary. This expert consensus converged on a tool that is now the most widely used in protocols studying concussion in sports at risk of BTI. This tool, the SCAT 5 (Sports Concussion Assessment Tool), combines symptom assessment, cognitive examination, neurological examination (oculomotricity, balance) and immediate and delayed memory. However, it requires the intervention of a medical expert to assess the clinical signs of the concussed athlete. Hänninen et al (2021) showed that test-retest reproducibility was very good for the clinical symptomatology subscore, but poor or average for the subscores summarizing cognitive tests and balance assessment. Clinicians now need to be able to better assess the severity of damage following head injury, and to monitor the patient's progress. This will improve the management of concussed athletes right up to their eventual return to sporting activity. The ultimate aim of our project is to develop and optimize an easily exportable multimodal concussion assessment tool, based on the use of a virtual reality headset, which will enable us to objectively characterize the state and evolution of a subject after a TCE. This will enable the assessment of neuro-visual functions and compensations in the concussed patient, revealing a higher attentional cost characterized by instability of orthostatic control, higher blink frequency and larger pupil size. The multimodal tool will be built from the results of various tests:

  • Standardized oculomotor tasks(pro-saccades, anti-saccades, smooth pursuit, memory guided saccades, self paced saccades)
  • Orthostatic balance control to assess postural compensations and estimate attentional cost during oculomotor tasks.
  • Pupil dynamics using the Pupil Cycle Time (PCT) test. The aim of this exploratory study is to determine the repeatability of measurements provided by the SPORTiCARE virtual reality headset during different tasks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 15, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

August 23, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2023

Completed
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

2 months

First QC Date

August 4, 2023

Last Update Submit

February 15, 2024

Conditions

Outcome Measures

Primary Outcomes (10)

  • Assessment of repeatability when performing pro-saccades

    Latency (ms)

    Day 0

  • Assessment of repeatability when performing anti-saccades

    Latency (ms)

    Day 0

  • Assessment of repeatability when performing memory tricks

    Positional error (degrees)

    Day 0

  • Assessment of repeatability of the number of saccades when performing self-paced saccades

    number of saccades (n) performed between the two targets in the allotted time (15 seconds)

    Day 0

  • Assessment of repeatability of pupil cycle time when performing self-paced saccades

    Pupil Cycle Time (PCT): average frequency of pupillary oscillation (Hz)

    Day 0

  • Assessment of repeatability when performing pro-saccades

    Latency (ms)

    Between Day 7 and Day 21

  • Assessment of repeatability when performing anti-saccades

    Latency (ms)

    Between Day 7 and Day 21

  • Assessment of repeatability when performing memory tricks

    Positional error (degrees)

    Between Day 7 and Day 21

  • Assessment of repeatability of the number of saccades when performing self-paced saccades

    number of saccades (n) performed between the two targets in the allotted time (15 seconds)

    Between Day 7 and Day 21

  • Assessment of repeatability of pupil cycle time when performing self-paced saccades

    Pupil Cycle Time (PCT): average frequency of pupillary oscillation (Hz)

    Between Day 7 and Day 21

Interventions

* Visual assessment to ensure that the subject meets the inclusion and non-inclusion criteria, including anamnesis and the following visual tests: Lang stereotest, H-test ocular motility, convergence, masking and accommodative rock. * Evaluation by experimenter A (60 min) * Neuro-ophthalmological tests on screen * Neuro-ophthalmological tests in VR headset * Evaluation by experimenter B (60 min) * Neuro-ophthalmological tests on screen * Neuro-ophthalmological tests in VR helmet The sequence of experimenters A-B or B-A will be randomized.

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Group of 25 healthy volunteers

You may qualify if:

  • Visual acuity of 10/10,
  • Express consent to participate in the study,
  • Affiliated (or beneficiary) of a social insurance scheme.

You may not qualify if:

  • History of Cranioencephalic Trauma,
  • Protected persons: pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure (guardianship or curatorship).
  • Subjects suffering from a degenerative disease or any other illness which could interfere with the evaluations planned during this study (migraine, balance disorders, vertigo).
  • Subjects with ophthalmological pathologies affecting visual functions (oculomotor dysfunction, diplopia, strabismus).
  • Known history of convergence and/or accommodation insufficiency.
  • Subject declaring to the investigator in charge of anamnesis, consumption of psychoactive and psychotropic drugs, medications (anti-anxiety, antidepressant, anticonvulsant, opiate, analgesic, anti-hypertensive) or level 3 medications, which may have effects on vision.
  • Unavailability of participant for evaluation sessions.
  • Inability to comply with study task instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Streetlab - Institut de la Vision

Paris, 75012, France

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2023

First Posted

August 15, 2023

Study Start

August 23, 2023

Primary Completion

November 2, 2023

Study Completion

November 2, 2023

Last Updated

February 16, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations